Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib

Fig 3

Overall survival based on response to first line therapy.

For responders and non-responders OS were 43.5 (95%CI 28.5-NR) and 25.3 (95%CI 22.3-NR) months, respectively.

Fig 3

doi: https://doi.org/10.1371/journal.pone.0217340.g003